These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3403261)

  • 1. [Active ingredients, pharmaceutic aids and efficacy of topical drugs].
    Zesch A
    Hautarzt; 1988 May; 39(5):267-9. PubMed ID: 3403261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galenics of dermal products--vehicles, properties and drug release.
    Daniels R; Knie U
    J Dtsch Dermatol Ges; 2007 May; 5(5):367-83. PubMed ID: 17451381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current guidelines applicable for the approval of topically applied dermatological drugs in the EU.
    Straube MD; Zesch A
    Fundam Clin Pharmacol; 2004 Oct; 18(5):503-11. PubMed ID: 15482371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic principles in local dermatologic therapy].
    Pflugshaupt C
    Ther Umsch; 1998 Aug; 55(8):470-7. PubMed ID: 9757812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy using dermatologic agents].
    Pflugshaupt C
    Ther Umsch; 1989 Feb; 46(2):89-93. PubMed ID: 2928984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin irritation by topical drugs.
    Zesch A
    Derm Beruf Umwelt; 1983; 31(3):74-8. PubMed ID: 6872867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in cosmetics and skin care products.
    Draelos ZD
    Adv Dermatol; 1997; 12():3-17; discussion 18. PubMed ID: 8973733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of bioavailability by lowering of fat content in topical formulations.
    Wirén K; Frithiof H; Sjöqvist C; Lodén M
    Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective topical dermatologic therapy.
    Cullen SI
    Dermatol Clin; 1989 Jan; 7(1):37-42. PubMed ID: 2646048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
    Worthington HE
    Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
    [No Abstract]   [Full Text] [Related]  

  • 14. The characteristics and utility of solid phase porous microspheres: a review.
    Smith S; Morhenn V; Webster G
    J Drugs Dermatol; 2006; 5(10):969-74. PubMed ID: 17373146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mystical effects of dermatological vehicles.
    Surber C; Smith EW
    Dermatology; 2005; 210(2):157-68. PubMed ID: 15724099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical drug vehicles--influence of galenics in the therapy of atopic eczema].
    Daniels R
    Med Monatsschr Pharm; 2008 Apr; 31(4):139-43. PubMed ID: 18497245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The reactive epidermoplasia of guinea pig skin as a testing method for dermatologic agents].
    Weirich EG; Schenk C
    Dermatologica; 1969; 139():Suppl II:1+. PubMed ID: 5375539
    [No Abstract]   [Full Text] [Related]  

  • 20. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.